Keyphrases
Nigeria
100%
COVID-19 Pandemic
52%
Virus
46%
Vaccination
38%
COVID-19
33%
IgG Antibody
28%
Ado-Ekiti
24%
Antenatal Clinic
23%
Escherichia Coli
23%
Africa
22%
Bacterial Pathogens
21%
Pregnant Women
21%
Southwest Nigeria
21%
Teaching Hospital
21%
Bacterial Contamination
20%
Infection Risk
19%
Ekiti
18%
Vaccine Hesitancy
17%
Staphylococcus Aureus
16%
IgM Antibody
16%
Selling
15%
Bacterial Isolates
15%
Seroprevalence
15%
Asia
15%
South America
15%
Low-middle Income Countries
14%
Eyeglasses
14%
Vaccine Development
14%
Chlamydia Trachomatis
14%
Tertiary Institutions
14%
Highly Active Antiretroviral Therapy (HAART)
14%
Herbal Remedies
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Immune Response
13%
Klebsiella Pneumoniae (K. pneumoniae)
13%
Infectious Diseases
12%
Coronavirus Disease 2019 Vaccine
12%
Coronavirus Disease 2019 Vaccination
11%
Ready-to-eat
10%
Nigerian Population
10%
Acceptance Rate
10%
Citrobacter
10%
Nigerians
10%
Ciprofloxacin
10%
Adverse Effects
9%
Pathogenic Bacteria
9%
Structured Questionnaire
9%
Thrombocytopenia
9%
Wistar Rats
9%
Ogun State
8%
Medicine and Dentistry
COVID-19
63%
Infection
40%
Public Health
22%
Pandemic
19%
Disease
18%
Cross Sectional Study
18%
Coronavirinae
17%
Human Immunodeficiency Virus
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Vaccine Development
12%
Vaccine Hesitancy
11%
Prevalence
11%
Platelet
10%
Thrombocytopenia
9%
Flight
9%
Hematocrit
8%
Erythrocyte Count
8%
Immunoglobulin M Antibody
7%
Pathogen
7%
Attitude
7%
Tumor Microenvironment
7%
Parvovirus B19
7%
Low and Middle Income Countries
7%
Chlamydia Trachomatis
7%
Sodium Fluoride
7%
Travel Medicine
7%
Antibiogram
7%
Bacterium Contamination
7%
Human Immunodeficiency Virus Vaccine
7%
Cell Count
7%
COVID-19 Vaccine
7%
Epidemic
7%
Highly Active Antiretroviral Therapy
7%
Alloantibody
7%
Thrombocyte Antigen
7%
Blood Dyscrasia
7%
Child Care
7%
Hemoglobins
7%
Experimental Infection
7%
Bone Marrow Cell
7%
Trypanosoma Brucei
7%
Reticulocyte
7%
Immunology
7%
Leukocyte
7%
Antiinfective Agent
7%
One Health
7%
Yellow Fever
7%
Study Participant
7%
Hemoglobin Determination
6%
Agar
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
25%
Disease
24%
Prevalence
23%
Coronavirinae
23%
Infectious Agent
21%
Escherichia coli
17%
Antiinfective Agent
16%
Chlamydia Trachomatis
14%
Eye Infection
14%
HIV
14%
Staphylococcus Aureus
13%
Antibiotics
12%
Cross-Sectional Study
10%
Klebsiella pneumoniae
9%
Citrobacter
9%
Pseudomonas aeruginosa
8%
Receptor
8%
Vaccine Development
8%
Ciprofloxacin
7%
Agar
7%
Immunoglobulin G Antibody
7%
Herbal Remedy
7%
Thrombocytopenia
7%
Immunoglobulin M Antibody
7%
Secukinumab
7%
Psoriatic Arthritis
7%
Interleukin 17
7%
Psoriasis Vulgaris
7%
Adverse Event
7%
Coliform Bacterium
7%
Inflammation
7%
Monoclonal Antibody
7%
Sodium Fluoride
7%
Toothpaste
7%
Antiphospholipid Antibody
7%
Protein Antibody
7%
Corticosterone
7%
Andrographis paniculata
7%
Ginger
7%
Human Immunodeficiency Virus Vaccine
7%
Human Papillomavirus
7%
SARS Coronavirus
7%
Aspartic Acid
7%
Blood Dyscrasia
7%
Thrombocyte Antigen
7%
Alloantibody
7%
COVID-19 Vaccine
7%
Bacterium Lipopolysaccharide
7%
Human Parvovirus B19
7%
C Reactive Protein
7%